Cargando…
Research and progress on ClC-2
Chloride channel 2 (ClC-2) is one of the nine mammalian members of the ClC family. The present review discusses the molecular properties of ClC-2, including CLCN2, ClC-2 promoter and the structural properties of ClC-2 protein; physiological properties; functional properties, including the regulation...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482133/ https://www.ncbi.nlm.nih.gov/pubmed/28534947 http://dx.doi.org/10.3892/mmr.2017.6600 |
_version_ | 1783245523521634304 |
---|---|
author | Wang, Hongwei Xu, Minghui Kong, Qingjie Sun, Peng Yan, Fengyun Tian, Wenying Wang, Xin |
author_facet | Wang, Hongwei Xu, Minghui Kong, Qingjie Sun, Peng Yan, Fengyun Tian, Wenying Wang, Xin |
author_sort | Wang, Hongwei |
collection | PubMed |
description | Chloride channel 2 (ClC-2) is one of the nine mammalian members of the ClC family. The present review discusses the molecular properties of ClC-2, including CLCN2, ClC-2 promoter and the structural properties of ClC-2 protein; physiological properties; functional properties, including the regulation of cell volume. The effects of ClC-2 on the digestive, respiratory, circulatory, nervous and optical systems are also discussed, in addition to the mechanisms involved in the regulation of ClC-2. The review then discusses the diseases associated with ClC-2, including degeneration of the retina, Sjögren's syndrome, age-related cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus. It was concluded that future investigations of ClC-2 are likely to be focused on developing specific drugs, activators and inhibitors regulating the expression of ClC-2 to treat diseases associated with ClC-2. The determination of CLCN2 is required to prevent and treat several diseases associated with ClC-2. |
format | Online Article Text |
id | pubmed-5482133 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-54821332017-06-28 Research and progress on ClC-2 Wang, Hongwei Xu, Minghui Kong, Qingjie Sun, Peng Yan, Fengyun Tian, Wenying Wang, Xin Mol Med Rep Review Chloride channel 2 (ClC-2) is one of the nine mammalian members of the ClC family. The present review discusses the molecular properties of ClC-2, including CLCN2, ClC-2 promoter and the structural properties of ClC-2 protein; physiological properties; functional properties, including the regulation of cell volume. The effects of ClC-2 on the digestive, respiratory, circulatory, nervous and optical systems are also discussed, in addition to the mechanisms involved in the regulation of ClC-2. The review then discusses the diseases associated with ClC-2, including degeneration of the retina, Sjögren's syndrome, age-related cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus. It was concluded that future investigations of ClC-2 are likely to be focused on developing specific drugs, activators and inhibitors regulating the expression of ClC-2 to treat diseases associated with ClC-2. The determination of CLCN2 is required to prevent and treat several diseases associated with ClC-2. D.A. Spandidos 2017-07 2017-05-18 /pmc/articles/PMC5482133/ /pubmed/28534947 http://dx.doi.org/10.3892/mmr.2017.6600 Text en Copyright: © Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Review Wang, Hongwei Xu, Minghui Kong, Qingjie Sun, Peng Yan, Fengyun Tian, Wenying Wang, Xin Research and progress on ClC-2 |
title | Research and progress on ClC-2 |
title_full | Research and progress on ClC-2 |
title_fullStr | Research and progress on ClC-2 |
title_full_unstemmed | Research and progress on ClC-2 |
title_short | Research and progress on ClC-2 |
title_sort | research and progress on clc-2 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482133/ https://www.ncbi.nlm.nih.gov/pubmed/28534947 http://dx.doi.org/10.3892/mmr.2017.6600 |
work_keys_str_mv | AT wanghongwei researchandprogressonclc2 AT xuminghui researchandprogressonclc2 AT kongqingjie researchandprogressonclc2 AT sunpeng researchandprogressonclc2 AT yanfengyun researchandprogressonclc2 AT tianwenying researchandprogressonclc2 AT wangxin researchandprogressonclc2 |